Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis

Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis. Cessation of treatment before the recommended conclusion may lead to the emergence of multidrug-resistant strains. The aim of this study was to develop nanostructured lipid carriers (NLCs) for use in the treatment of M. tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Mariana R, Oshiro Junior, João A, Machado, Rachel TA, de Souza, Paula C, Campos, Débora L, Pavan, Fernando R, da Silva, Patricia B, Chorilli, Marlus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367736/
https://www.ncbi.nlm.nih.gov/pubmed/28356717
http://dx.doi.org/10.2147/DDDT.S127048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367736/
https://www.ncbi.nlm.nih.gov/pubmed/28356717
http://dx.doi.org/10.2147/DDDT.S127048

Ejemplares similares